Raghuveer Halkar, MD

Role

Nuclear Medicine
Specialty

Adrenal Cancer Brain and Spine Tumors Neuroendocrine Tumors Thyroid Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

1992

Background

A board certified nuclear medicine physician, Raghuveer K. Halkar, MD, has clinical expertise in thyroid cancer and neuroendocrine tumor management. Dr. Halkar’s area of research interest is imaging and therapy with radio-labeled folate. He serves as the Director of Nuclear Radiology at Grady Memorial Hospital.

Dr. Halkar serves on the board of directors of the Intersocietal Accreditation Committee and as a grant reviewer for Department of Defense and National Institutes of Health study sections.

Titles & Roles

Director, Nuclear Medicine

Grady Memorial Hospital
Professor, Department of Radiology

Emory University School of Medicine

Education & Training

Education

Fellowship, Nuclear Medicine, 1992
Creighton Univ Afiliated Hospitals
Residency, Nuclear Medicine, 1991
Emory University School of Medicine
Residency, 1980
All India Institute of Medical Sciences-IND
Medical Education, MD, 1976
Government Medical College-IND
Internship, 1976
Government Medical College-IND

Board Certifications

Nuclear Medicine
American Board of Nuclear Medicine, 1991

Professional Memberships

Academy of Molecular Imaging
Society of Nuclear Medicine

Research

Publications

Title/Journal	Authors	Publication Date
Prostate Cancer Skeletal Metastasis: A Spontaneous Evolution from Osteolytic to Osteoblastic Morphology without Treatment. World journal of nuclear medicine	IO Lawal, MA Bilen, RK Halkar, AB Jani, DM Schuster	12/01/2023
Aberrant Vascular Anatomy Associated With Artifactual Focal Avidity in the Liver on PSMA PET. Clinical nuclear medicine	IO Lawal, M Pectasides, AS Parihar, HU Shah, RK Halkar, AB Jani, DM Schuster	09/01/2023
Computer assisted interpretation of Tc-99m mercaptoacetyltriglycine diuretic scintigraphy enhances resident performance. Nuclear medicine communications	AT Taylor, AKM Fazlur Rahman, RD Folks, V Moncayo, B Savir-Baruch, N Plaxton, A Polsani, RK Halkar, EV Dubovsky, EV Garcia, A Manatunga	06/01/2023
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical nuclear medicine	IO Lawal, C Marcus, DM Schuster, S Goyal, OA Adediran, VR Dhere, SS Joshi, OA Abiodun-Ojo, VA Master, PR Patel, B Fielder, M Goodman, JW Shelton, O Kucuk, B Hershatter, RK Halkar, AB Jani	04/01/2023
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus ¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	IO Lawal, AB Jani, OA Adediran, S Goyal, OA Abiodun-Ojo, VR Dhere, CV Marcus, SS Joshi, VA Master, PR Patel, M Goodman, JW Shelton, O Kucuk, B Hershatter, B Fielder, RK Halkar, DM Schuster	04/01/2023
Root Cause Analysis in Nuclear Medicine for Sentinel Events. Journal of nuclear medicine technology	J Dhingra, MB Farrell, RK Halkar	10/04/2022
Can the Diagnostic Accuracy of Bone Scintigraphy Be Maintained with Half the Scanning Time? Journal of nuclear medicine technology	VM Moncayo, S Chimafor, E Lulaj, JA Malko, R Halkar	12/01/2021
Root Cause Analysis of Na¹³¹I Contamination. Journal of nuclear medicine technology	J Dhingra, C Santana, J Harvey, A Miller, A Benton, M Childs, R Halkar	12/01/2021
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on ¹⁸F-Fluciclovine PET/CT Guidance. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	OA Abiodun-Ojo, AB Jani, AA Akintayo, OO Akin-Akintayo, OA Odewole, FI Tade, SS Joshi, VA Master, B Fielder, RK Halkar, C Zhang, S Goyal, MM Goodman, DM Schuster	08/01/2021
¹⁸F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet (London, England)	AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, VA Master, SS Joshi, O Kucuk, BC Carthon, MA Bilen, OA Abiodun-Ojo, AA Akintayo, VR Dhere, DM Schuster	05/22/2021
Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer. Clinical nuclear medicine	OA Abiodun-Ojo, AA Akintayo, LR Harik, M Bilen, RK Halkar	05/01/2021
Head to head comparison of [^99mTc]Tc(CO)₃(NTA) and [^99mTc]Tc-MAG3 in patients with suspected obstruction. EJNMMI research	AT Taylor, M Lipowska, RK Halkar	05/01/2021
Proximal and Distal Gastric Retention Patterns in Gastroparesis and the Impact of Gastric Per-Oral Endoscopic Myotomy: A Retrospective Analysis Using Gastric Emptying Scintigraphy. Journal of nuclear medicine technology	R Spandorfer, Y Zhu, MM Abdelfatah, P Mekaroonkamol, S Dacha, JR Galt, R Halkar, Q Cai	06/01/2020
Gastric Emptying Scintigraphy Before Gastric per Oral Endoscopic Myotomy: Imaging May Inform Treatment. Gastrointestinal endoscopy clinics of North America	RM Spandorfer, Y Zhu, P Mekaroonkamol, J Galt, R Halkar, Q Cai	01/01/2019
Prospective evaluation of fluciclovine (¹⁸F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients. European journal of radiology	O Akin-Akintayo, F Tade, P Mittal, C Moreno, PT Nieh, P Rossi, D Patil, R Halkar, B Fei, V Master, AB Jani, H Kitajima, AO Osunkoya, C Ormenisan-Gherasim, MM Goodman, DM Schuster	05/01/2018
Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome. Clinical nuclear medicine	SY Yim, VM Moncayo, FJ Pasquel, RK Halkar	12/01/2017
^99mTc-MAG₃: Image Wisely. Radiology	AT Taylor, RD Folks, AKMF Rahman, A Polsani, EV Dubovsky, R Halkar, A Manatunga	07/01/2017
Imaging of Parathyroid Glands in End Stage Renal Disease. Seminars in dialysis	J Sharma, R Halkar, CJ Weber	07/01/2017
Impact of ¹⁸F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	AB Jani, E Schreibmann, PJ Rossi, J Shelton, K Godette, P Nieh, VA Master, O Kucuk, M Goodman, R Halkar, S Cooper, Z Chen, DM Schuster	03/01/2017
Survey on the Use of Nuclear Renal Imaging in the United States. Journal of nuclear medicine technology	RK Halkar, AT Taylor	03/01/2017
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer. Clinical nuclear medicine	OO Akin-Akintayo, AB Jani, O Odewole, FI Tade, PT Nieh, VA Master, LM Bellamy, RK Halkar, C Zhang, Z Chen, MM Goodman, DM Schuster	01/01/2017
A Novel Timesaving Method for Hepatobiliary Imaging for Suspected Acute Cholecystitis. Current problems in diagnostic radiology	SS Carter, SR Ehsan, R Duszak, DJ Lee, FP Esteves, DC Brandon, RK Halkar	01/01/2017
Radionuclide Therapies in Molecular Imaging and Precision Medicine. PET clinics	AT Kendi, VM Moncayo, JA Nye, JR Galt, R Halkar, DM Schuster	01/01/2017
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT. European journal of nuclear medicine and molecular imaging	OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, PJ Rossi, RK Halkar, AO Osunkoya, O Akin-Akintayo, C Zhang, Z Chen, MM Goodman, DM Schuster	09/01/2016
Assessment of the Role of Different Imaging Modalities with Emphasis on Fdg Pet/Ct in the Management of Well Differentiated Thyroid Cancer (WDTC). Journal of thyroid disorders & therapy	TK Kendi A, S Mudalegundi, J Switchenko, D Lee, R Halkar, AY Chen	01/01/2016
Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings. AJR. American journal of roentgenology	NA Plaxton, DC Brandon, AS Corey, CE Harrison, AT Karagulle Kendi, RK Halkar, BJ Barron	11/01/2015
The nuclear medicine therapy care coordination service: a model for radiologist-driven patient-centered care. Academic radiology	VM Moncayo, KE Applegate, R Duszak, BJ Barron, J Fitz, RK Halkar, DJ Lee, DM Schuster	06/01/2015
Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis. Molecular imaging and biology	OA Odewole, OA Oyenuga, F Tade, B Savir-Baruch, PT Nieh, V Master, Z Chen, X Wang, AB Jani, LM Bellamy, RK Halkar, MM Goodman, DM Schuster	04/01/2015
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	DM Schuster, C Nanni, S Fanti, S Oka, H Okudaira, Y Inoue, J Sörensen, R Owenius, P Choyke, B Turkbey, TV Bogsrud, T Bach-Gansmo, RK Halkar, JA Nye, OA Odewole, B Savir-Baruch, MM Goodman	12/01/2014
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. The Journal of urology	DM Schuster, PT Nieh, AB Jani, R Amzat, FD Bowman, RK Halkar, VA Master, JA Nye, OA Odewole, AO Osunkoya, B Savir-Baruch, P Alaei-Taleghani, MM Goodman	05/01/2014
Expression of functional folate receptors by human parathyroid cells. Surgery	CJ Weber, S Müller, SA Safley, KB Gordon, P Amancha, F Villinger, VM Camp, M Lipowska, J Sharma, C Müller, R Schibli, PS Low, CP Leamon, RK Halkar	12/01/2013
Imaging quality of F-18-FDG PET/CT in the inpatient versus outpatient setting. Annals of nuclear medicine	X Yan, J Kang, Y Zhou, R Ehsan, R Halkar, KE Applegate, DM Schuster	07/01/2013
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. American journal of nuclear medicine and molecular imaging	DM Schuster, PA Taleghani, PT Nieh, VA Master, R Amzat, B Savir-Baruch, RK Halkar, T Fox, AO Osunkoya, CS Moreno, JA Nye, W Yu, B Fei, Z Wang, Z Chen, MM Goodman	01/01/2013
iRENEX: a clinically informed decision support system for the interpretation of ⁹⁹mTc-MAG3 scans to detect renal obstruction. European journal of nuclear medicine and molecular imaging	EV Garcia, A Taylor, R Folks, D Manatunga, R Halkar, B Savir-Baruch, E Dubovsky	09/01/2012
Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma. Molecular imaging and biology	B Savir-Baruch, DM Schuster, N Jarkas, VA Master, PT Nieh, RK Halkar, JA Nye, MM Lewis, RJ Crowe, RJ Voll, VM Camp, LM Bellamy, DL Roberts, MM Goodman	12/01/2011
Incremental benefit of SPECT + CT bone scans over conventional planar and SPECT bone scans in vertebroplasty. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India	K Kumar, RK Halkar, SC Bartley, DM Schuster	10/01/2011
Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT. Clinical nuclear medicine	R Amzat, P Taleghani, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, MM Lewis, M Faurot, LM Bellamy, MM Goodman, DM Schuster	09/01/2011
Extravasation of a therapeutic dose of 131I-metaiodobenzylguanidine: prevention, dosimetry, and mitigation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	DV Bonta, RK Halkar, N Alazraki	09/01/2011
Role of FDG-PET in the definition of involved-field radiation therapy and management for pediatric Hodgkin's lymphoma. International journal of radiation oncology, biology, physics	VL Robertson, CS Anderson, FG Keller, R Halkar, M Goodman, RB Marcus, N Esiashvili	06/01/2011
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. Radiology	DM Schuster, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, PJ Rossi, MM Lewis, JA Nye, W Yu, FD Bowman, MM Goodman	06/01/2011
Absent coronary artery calcium excludes inducible myocardial ischemia on computed tomography/positron emission tomography. International journal of cardiology	FP Esteves, A Khan, LC Correia, JA Nye, RK Halkar, DM Schuster, A Stillman, P Raggi	03/17/2011
The role of single-photon emission computed tomography and SPECT/computed tomography in oncologic imaging. Seminars in oncology	D Brandon, A Alazraki, RK Halkar, NP Alazraki	02/01/2011
A 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function. Urology	A Taylor, A Manatunga, R Halkar, MM Issa, NV Shenvi	12/01/2010
In vivo assay of folate receptors in nonfunctional pituitary adenomas with 99mTc-folate SPECT/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	JR Galt, RK Halkar, CO Evans, NA Osman, D LaBorde, TH Fox, BA Faraj, K Kumar, H Wang, NM Oyesiku	11/01/2010
Prompt-gamma compensation in Rb-82 myocardial perfusion 3D PET/CT. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology	FP Esteves, JA Nye, A Khan, RD Folks, RK Halkar, EV Garcia, DM Schuster, S Lerakis, P Raggi, JR Votaw	04/01/2010
Extramedullary acute myeloid leukemia and the use of FDG-PET/CT. Clinical nuclear medicine	S Rao, A Langston, JR Galt, RK Halkar	06/01/2009
Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clinical nuclear medicine	W Zeng, MJ Lechowicz, E Winton, SM Cho, JR Galt, R Halkar	06/01/2009
Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma. Molecular imaging and biology	DM Schuster, JA Nye, PT Nieh, JR Votaw, RK Halkar, MM Issa, W Yu, J Sepulveda, W Zeng, A Young, MM Goodman	01/01/2009
Diagnostic performance of an expert system for interpretation of 99mTc MAG3 scans in suspected renal obstruction. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	A Taylor, EV Garcia, JN Binongo, A Manatunga, R Halkar, RD Folks, E Dubovsky	02/01/2008
Investigation of emission-transmission misalignment artifacts on rubidium-82 cardiac PET with adenosine pharmacologic stress. Molecular imaging and biology	DM Schuster, RK Halkar, FP Esteves, EV Garcia, CD Cooke, MA Syed, FD Bowman, JR Votaw	01/01/2008

Awards

Dr. Halkar received the Marshall Brucer Award from the Southeastern Chapter of SNMMI in 2012 for his contributions to Nuclear Medicine.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.